Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography.
Brugaletta S, Garcia-Garcia HM, Serruys PW, de Boer S, Ligthart J, Gomez-Lara J, Witberg K, Diletti R, Wykrzykowska J, van Geuns RJ, Schultz C, Regar E, Duckers HJ, van Mieghem N, de Jaegere P, Madden SP, Muller JE, van der Steen AF, van der Giessen WJ, Boersma E. Brugaletta S, et al. Among authors: wykrzykowska j. JACC Cardiovasc Imaging. 2011 Jun;4(6):647-55. doi: 10.1016/j.jcmg.2011.03.013. JACC Cardiovasc Imaging. 2011. PMID: 21679900 Free article.
Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
Magro M, Wykrzykowska J, Serruys PW, Simsek C, Nauta S, Lesiak M, Stanislawska K, Onuma Y, Regar E, van Domburg RT, Grajek S, Geuns RJ. Magro M, et al. Among authors: wykrzykowska j. Catheter Cardiovasc Interv. 2011 May 1;77(6):798-806. doi: 10.1002/ccd.22767. Epub 2011 Mar 8. Catheter Cardiovasc Interv. 2011. PMID: 20824767
The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer.
Garg S, Wykrzykowska J, Serruys PW, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Tyczynski P, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P, Windecker S. Garg S, et al. Among authors: wykrzykowska j. EuroIntervention. 2011 Mar;6(8):928-35. doi: 10.4244/EIJV6I8A162. EuroIntervention. 2011. PMID: 21330239 Free article. Clinical Trial.
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study.
Sarno G, Garg S, Gomez-Lara J, Garcia Garcia HM, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns RJ, de Boer S, Wykrzykowska J, Schultz C, Duckers HJ, Regar E, de Jaegere P, de Feyter P, van Es GA, Boersma E, van der Giessen W, Serruys PW; ATHEROREMO Study Investigators. Sarno G, et al. Among authors: wykrzykowska j. EuroIntervention. 2011 Mar;6(8):977-84. doi: 10.4244/EIJV6I8A169. EuroIntervention. 2011. PMID: 21330246 Clinical Trial.
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.
Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S. Garg S, et al. Among authors: wykrzykowska j. JACC Cardiovasc Interv. 2011 Apr;4(4):432-41. doi: 10.1016/j.jcin.2011.01.008. JACC Cardiovasc Interv. 2011. PMID: 21511223 Free article. Clinical Trial.
Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography.
Gutiérrez-Chico JL, Regar E, Nüesch E, Okamura T, Wykrzykowska J, di Mario C, Windecker S, van Es GA, Gobbens P, Jüni P, Serruys PW. Gutiérrez-Chico JL, et al. Among authors: wykrzykowska j. Circulation. 2011 Aug 2;124(5):612-23. doi: 10.1161/CIRCULATIONAHA.110.014514. Epub 2011 Jul 18. Circulation. 2011. PMID: 21768536
The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).
Wykrzykowska J, Serruys P, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, Di Mario C, Van Geuns RJ, Van Es GA, Juni P, Windecker S. Wykrzykowska J, et al. EuroIntervention. 2011 Nov;7(7):789-95. doi: 10.4244/EIJV7I7A125. EuroIntervention. 2011. PMID: 22027687 Free article. Clinical Trial.
Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography.
Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, van Geuns RJ, Koch KT, Koolen JJ, di Mario C, Windecker S, van Es GA, Gobbens P, Jüni P, Regar E, Serruys PW. Gutiérrez-Chico JL, et al. Among authors: wykrzykowska j. Circ Cardiovasc Interv. 2012 Feb 1;5(1):20-9, S1-8. doi: 10.1161/CIRCINTERVENTIONS.111.965301. Epub 2012 Feb 7. Circ Cardiovasc Interv. 2012. PMID: 22319063
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the Netherlands.
Everaert B, Felix C, Koolen J, den Heijer P, Henriques J, Wykrzykowska J, van der Schaaf R, de Smet B, Hofma S, Diletti R, Van Mieghem N, Regar E, Smits P, van Geuns RJ. Everaert B, et al. Among authors: wykrzykowska j. Neth Heart J. 2015 Mar;23(3):161-5. doi: 10.1007/s12471-015-0651-3. Neth Heart J. 2015. PMID: 25626696 Free PMC article.
274 results